Vadimezan
|
|
|
- CAS-Nr.
- 117570-53-3
- Englisch Name:
- Vadimezan
- Synonyma:
- DMXAA;DMAXX;AS1404;ASA-404;CS-1975;AS 1404;AS-1404;vadimezan;NSC-649488;NSC-640488
- CBNumber:
- CB5503379
- Summenformel:
- C17H14O4
- Molgewicht:
- 282.29
- MOL-Datei:
- 117570-53-3.mol
|
Vadimezan Eigenschaften
- Schmelzpunkt:
- 259-261 °C
- Siedepunkt:
- 520.9±50.0 °C(Predicted)
- Dichte
- 1.321±0.06 g/cm3(Predicted)
- Dampfdruck
- 0Pa at 20℃
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: 17 mg/mL, soluble
- Aggregatzustand
- solid
- pka
- 4.21±0.10(Predicted)
- Farbe
- light brown
- Stabilit?t:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or DMF may be stored at -20°C for up to 3 months.
- InChI
- InChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)
- InChIKey
- XGOYIMQSIKSOBS-UHFFFAOYSA-N
- SMILES
- C1(=O)C2=C(C(C)=C(C)C=C2)OC2=C1C=CC=C2CC(O)=O
Vadimezan Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R22:Gesundheitssch?dlich beim Verschlucken.
R50/53:Sehr giftig für Wasserorganismen, kann in Gew?ssern l?ngerfristig sch?dliche Wirkungen haben.
S-S?tze Betriebsanweisung:
S60:Dieses Produkt und sein Beh?lter sind als gef?hrlicher Abfall zu entsorgen.
S61:Freisetzung in die Umwelt vermeiden. Besondere Anweisungen einholen/Sicherheitsdatenblatt zu Rate ziehen.
Definition
ChEBI: A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 5,6-dimethyl-9-oxoxanthen-4-yl group.
Allgemeine Beschreibung
5,6-dimethylxanthenone-4-acetic acid (DMXAA) is a flavone acetic acid derivative. It acts as a vascular disrupting agent (VDA), which damages tumor vasculature and stimulates an anti-tumor immune response. It stimulates hemorrhagic necrosis.
Vadimezan Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Vadimezan Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 253)Lieferanten
117570-53-3()Verwandte Suche:
- 5,6-dimethylxanthenoneacetic acid
- DMXAA
- vadimezan
- (5,6-DIMETHYL-9-OXO-XANTHEN)-4-ACETIC ACID
- 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid
- 5,6-Dimethylxanthenone-4-acetic acid
- NSC-640488
- NSC-649488
- ASA-404
- DMXAA(ASA404)
- 5,6-Dimethylxantheonone-4-acetic acid(DMXAA) ,98%
- DMXAA,5,6-Dimethylxanthenone-4-acetic Acid, ASA404, Vadimezan
- DMXAA Vadimezan
- VadiMezan(DMXAA,NSC 640488)
- DMXAA(AS1404,ASA404)
- 5,6-DiMethyl-9-oxo-9H-xanthene-4-acetic acid DMXAA, ASA404
- 5,6-Dimethylxantheonone-4-acetic acid
- DMXAA, >=99%
- DMAXX
- 9H-Xanthene-4-aceticacid, 5,6-dimethyl-9-oxo-
- CS-1975
- DMXAA (ASA404,Vadimezan)
- 2-(5,6-Dimethyl-9-oxoxanthen-4-yl)acetic Acid
- 5,6-Dimethylxantheonone-4-acetic acid USP/EP/BP
- Vadimezan (DMXAA, NSC640488, ASA404)
- Vadimezan DMXAA
- DMXAA/5,6-Dimethylxantheonone-4-acetic acid
- AS 1404
- AS1404
- AS-1404
- DMXAA (Vadimezan，ASA-204)
- Pentoxifylline Impurity 11
- (5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
- Vadimezan, 10 mM in DMSO
- DMXAA[D5817]
- 117570-53-3
- 11570-53-3
- Inhibitors
